Session 107 - 12th CROI

Home

Session 107 Poster Abstracts
Generic Antiretroviral Therapy
Wednesday, 1:30 - 3:30 pm
Hall A

630	Effectiveness of Generic Efavirenz-based HAART in HIV-1-infected Patients in India, a 2-year Follow-up Atul Patel*¹, R Sharma¹, E Naik², and N Shah¹ ¹Sterling Hosp, Ahmedabad, INDIA and ²Univ of South Florida, Tampa, USA
631	Pharmacokinetic Comparison of Generic and Trade Formulations of Lamivudine, Stavudine, and Nevirapine in 12 HIV-infected Malawian Subjects Mina Hosseinipour*¹, A Corbett², C Kanyama¹, I Mshali¹, S Chinyama¹, S Phakati¹, N Rezk², S White², I Hoffman², C Van der Horst², and A Kashuba² ¹Univ of North Carolina Project, Lilongwe, Malawi and ²Univ of North Carolina at Chapel Hill, USA
632	Community-based Generic Antiretroviral Therapy following Single-dose Nevirapine or Short-course AZT in Zimbabwe Lynn Zijenah*¹, G Kadzirange², S Rusakaniko¹, T Kupfa³, O Tobaiwa¹, S Moyo⁴, N Gonah², G Woelk¹, C Maponga¹, E Matsikire⁴, G Musingwini⁴, D Katzenstein⁵, and Doris Duke Charitable Trust Zimbabwe AIDS Prevention Project ¹Univ of Zimbabwe, Harare; ²Chitungwiza Hlth Dept, Harare, Zimbabwe; ³Medicin Sans Frontier, Harare, Zimbabwe; ⁴Zimbabwe AIDS Prevention Project, Harare; and ⁵Stanford Univ, CA, USA